Library / regulatory-reference
Ethiopia: Ethiopian Food and Drug Authority (EFDA)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Ethiopian Food and Drug Authority is Ethiopia's national regulator for medicines, medical devices, food and related health products, operating under the federal health ministry.
Ethiopia is Africa's second most populous country, and the authority oversees a market in rapid transition: a historically import-dependent supply with a growing domestic manufacturing push backed by industrial-park development.
How products enter the market
Medicines require registration before marketing, with evaluation of quality, safety and efficacy and a product register maintained by the authority. Import and distribution are licensed, and the authority inspects both domestic and foreign manufacturing sites supplying the Ethiopian market.
Medical devices fall under its registration remit, and the authority has been expanding its laboratory and inspection capacity as domestic production grows.
Regional and international role
The authority is an active participant in African regulatory harmonization and continental capacity-building, and Ethiopia hosts major continental institutions, giving its regulatory development outsized visibility.
Its trajectory, from basic registration toward reliance-informed pathways and stronger manufacturing oversight, is a closely watched case of regulatory system building in a large, fast-changing market.
Using this profile
The authority publishes registers, guidance and announcements, with English and Amharic material, through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: the Ethiopian authority illustrates the system-building regulator: expanding registration, laboratory and inspection capacity in step with a deliberate national push toward pharmaceutical self-sufficiency.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.